Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 14: 1158364, 2023.
Article in English | MEDLINE | ID: mdl-37342344

ABSTRACT

Background: Parkinson's Disease (PD) is one of the most common neurodegenerative diseases. PD has recently received more attention by researchers in the midst of the COVID-19 pandemic. Objective: Yet to be researched is the effect of the COVID-19 vaccines on PD patients. Several PD patients are still hesitant to the vaccine due to this unaddressed fear. The purpose of this study is to address this gap. Methods: Surveys were administered to PD patients 50 years and older at UF Fixel Institute who received at least one dose of the COVID-19 vaccine. Survey questions included patients' severity of PD symptoms before and after the vaccine and extent of worsening PD symptoms post-vaccination. After three weeks of collecting responses, the data was analyzed. Results: 34 respondents were eligible for data consideration because they fell within the age range being studied. A total of 14 respondents out of 34 (41%, p=0. 0001) reported that their PD symptoms worsened after the COVID-19 vaccine to some extent. Conclusion: There was strong evidence of worsening of PD symptoms post COVID-19 vaccination, however it was mostly mild and limited to a couple of days. The worsening had statistically significant moderate positive correlation with vaccine hesitancy and post-vaccine general side effects. A possible causative mechanism of PD symptom worsening using existing scientific knowledge would be stress and anxiety associated with vaccine hesitancy and the extent of post-vaccine general side effects (fever, chills, pain), likely via simulating a mild systemic infection/inflammation the latter already established causes of PD symptom worsening.


Subject(s)
COVID-19 Vaccines , COVID-19 , Drug-Related Side Effects and Adverse Reactions , Parkinson Disease , Humans , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Pandemics , Symptom Flare Up
2.
Oral Oncol ; 128: 105854, 2022 05.
Article in English | MEDLINE | ID: mdl-35447565

ABSTRACT

We present 8-year follow-up on the first patient with stage 4 ameloblastoma carrying a BRAF V600E mutation treated with dual BRAF/MEK inhibition (BRAF/MEKi). He experienced a durable clinical response while on dabrafenib (BRAFi) and trametinib (MEKi) without toxicity nor evidence for drug-resistant tumor progression. He was asymptomatic when he self-discontinued therapy after 4 years of sustained clinical response. He did not return for follow-up until 2.5 years later with onset of painful mandibular tumor recurrence associated with recurrent bilateral lung metastases. He was rechallenged with dabrafenib/trametinib and experienced another prompt tumor response and remains in a second durable clinical remission (currently > 16 months) on continuous dual targeted therapy. We discuss the implications of this case study for future treatment strategies.


Subject(s)
Ameloblastoma , Melanoma , Ameloblastoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Follow-Up Studies , Humans , Male , Melanoma/drug therapy , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinase Kinases/therapeutic use , Mutation , Proto-Oncogene Proteins B-raf/genetics , Pyridones/therapeutic use
3.
Clin Imaging ; 81: 103-106, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34695722

ABSTRACT

Acute bacterial sinusitis may be complicated by orbital and intracranial involvement and by thrombophlebitis. Its spread across multiple anatomic compartments is facilitated by the interconnected venous anatomy of the head and neck and the virulence of the primary pathogen. We present a rare case of Streptococcus Intermedius (S. Intermedius) acute bacterial sinusitis complicated by extensive skull base involvement including cavernous sinuses and neck vein thrombophlebitis and thrombosis.


Subject(s)
Sinusitis , Sphenoid Sinusitis , Thrombophlebitis , Humans , Skull Base/diagnostic imaging , Streptococcus intermedius
4.
Clin Imaging ; 77: 130-134, 2021 Sep.
Article in English | MEDLINE | ID: mdl-33677405

ABSTRACT

Cerebral ischemia results in disruption of the blood-brain barrier (BBB) allowing leakage of gadolinium-based contrast media (GBCM) into cerebrospinal fluid (CSF) within the craniospinal and perineural subarachnoid spaces (SAS). This phenomenon is well visualized with fluid-attenuated inversion recovery MRI techniques and allows for visualization of CSF flow dynamics. We present a case of ischemia-induced BBB disruption resulting in accumulation of GBCM in the SAS and ocular chambers as well as within the precorneal tear film and nasolacrimal duct. We present imaging evidence for a hypothetical alternate CSF absorption pathway through the ocular structures in keeping with prior experimental evidence.


Subject(s)
Blood-Brain Barrier , Gadolinium , Blood-Brain Barrier/diagnostic imaging , Brain , Cerebrospinal Fluid , Contrast Media , Gadolinium DTPA , Humans , Ischemia , Magnetic Resonance Imaging
5.
Acta Otolaryngol ; 140(11): 889-892, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32804558

ABSTRACT

BACKGROUND: Perilymph gusher (PLG) is a rare complication of otologic surgery attributed to a communication between the cochlea and the internal auditory canal (IAC). Subtle patency between the cochlear basal turn and IAC has recently been identified on computed tomography (CT) as a risk factor, specifically when the defect is > 0.75 mm. OBJECTIVES: Investigate the prevalence of radiographic cochlear basal turn patency. MATERIALS AND METHODS: Patients with CT of the temporal bones and inner ears interpreted as "normal" were included. An otologist and a radiologist independently reviewed CTs to measure radiographic dehiscence in an oblique plane along the interface of the cochlea and IAC. Known PLGs were excluded. RESULTS: Two hundred and ten ears were included (88 conductive or mixed hearing loss, 62 sensorineural hearing loss, 41 audiometrically normal ears). 71 ears (33.8%) were radiographically patent. Mean defect width was 0.41 mm (0.15-0.7 mm). Defect width was not associated with type of hearing loss, age, or gender. No defects were wider than 0.75 mm. CONCLUSIONS: Radiographic patency of the cochlear basal turn may be present in patients with hearing loss and normal hearing, but patency > 0.75 mm (i.e. risk for PLG) is rare.


Subject(s)
Cochlea/diagnostic imaging , Ear, Inner/diagnostic imaging , Fistula/diagnostic imaging , Labyrinth Diseases/diagnostic imaging , Perilymph , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cochlea/pathology , Ear, Inner/pathology , Female , Hearing Loss/etiology , Humans , Male , Middle Aged , Temporal Bone/diagnostic imaging , Tomography, X-Ray Computed , Young Adult
6.
Int J Pediatr Otorhinolaryngol ; 126: 109601, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31369970

ABSTRACT

OBJECTIVES: Perilymph gusher (PLG), an uncommon complication of otologic surgery, has been attributed to communication between the cochlea and the internal auditory canal (IAC). Subtle osseous defects may be missed on routine review of computed tomography (CT). This study aimed to quantify cochlear basal turn patency not seen on axial CT in patients with PLG and compare those against patients without intraoperative PLG. METHODS: Ears that underwent cochlear implantation or stapedotomy with preoperative helical CT that was interpreted as "normal" at a tertiary referral center. An otologist and a radiologist independently and in a blinded fashion measured the dimensions of cochlear basal turn patency on CT images in oblique plane and parasagittal planes along the interface of the cochlea and IAC fundus. RESULTS: Sixty-one ears were reviewed, including 3 with surgically confirmed PLGs and 12 with apparent dehiscence without a PLG. Mean defect width with PLG was 0.83 mm (range 0.75-0.9 mm) and without PLG was 0.43 mm (range 0.3-0.65 mm, p = 0.011). A greater proportion of PLGs occurred in ears with defects (3 of 15) than in ears without (0 of 46, p = 0.013). Using a cutoff of 0.75 mm, a greater proportion of PLGs occurred with defect width >0.75 mm (3 of 3) than in defects <0.75 mm (0 of 12, p = 0.022). CONCLUSIONS: CT dehiscence between the IAC and cochlear basal turn, particularly with a width > 0.75 mm, should be considered a risk for PLG with stapedotomy or cochlear implantation.


Subject(s)
Cochlear Implantation , Ear, Inner/abnormalities , Intraoperative Complications/etiology , Perilymph , Stapes Surgery , Adolescent , Adult , Aged , Aged, 80 and over , Child , Cochlea/abnormalities , Cochlea/diagnostic imaging , Ear, Inner/diagnostic imaging , Female , Humans , Intraoperative Complications/diagnosis , Male , Middle Aged , Preoperative Care , Retrospective Studies , Single-Blind Method , Tomography, Spiral Computed , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...